Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Albelda

Showing results (121-130 of 197) with videos related to

Pageof 20
Sort By:
Lung Cancer (Amsterdam, Netherlands)|February 9, 2021
Serum soluble mesothelin-related protein (SMRP) and fibulin-3 levels correlate with baseline malignant pleural mesothelioma (MPM) tumor volumes but are not useful as biomarkers of response in an immunotherapy trialSharyn I Katz, Leonid Roshkovan, Ian Berger, et al.
Science Translational Medicine|October 5, 2012
Prevention of alveolar destruction and airspace enlargement in a mouse model of pulmonary lymphangioleiomyomatosis (LAM)Elena A Goncharova, Dmitry A Goncharov, Melane Fehrenbach, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 21, 2009
Targeted detoxification of selected reactive oxygen species in the vascular endotheliumVladimir V Shuvaev, Melpo Christofidou-Solomidou, Faiz Bhora, et al.
Journal of Critical Care|October 1, 2011
Lower serum endocan levels are associated with the development of acute lung injury after major traumaMark E Mikkelsen, Chirag V Shah, Arnaud Scherpereel, et al.
Breast Cancer Research and Treatment|March 16, 2012
Mesothelin, a novel immunotherapy target for triple negative breast cancerJulia Tchou, Liang-Chuan Wang, Ben Selven, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapyDaniel H Sterman, Adriana Recio, Anil Vachani, et al.
American Journal of Respiratory Cell and Molecular Biology|April 17, 2004
Role for platelet-endothelial cell adhesion molecule-1 in macrophage Fcgamma receptor functionSteven M Albelda, Kelvin C Lau, Paul Chien, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Gene expression profiling of malignant mesotheliomaSunil Singhal, Rainer Wiewrodt, Liliana D Malden, et al.
Biomaterials|October 24, 2007
Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapiesThomas D Dziubla, Vladimir V Shuvaev, Nan Kang Hong, et al.
Lung Cancer (Amsterdam, Netherlands)|November 5, 2019
Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracyJeffrey C Thompson, Wei-Ting Hwang, Christiana Davis, et al.
Pageof 20

Showing results (121-130 of 197) with videos related to

Sort By:
Pageof 20
Lung Cancer (Amsterdam, Netherlands)|February 9, 2021
Serum soluble mesothelin-related protein (SMRP) and fibulin-3 levels correlate with baseline malignant pleural mesothelioma (MPM) tumor volumes but are not useful as biomarkers of response in an immunotherapy trialSharyn I Katz, Leonid Roshkovan, Ian Berger, et al.
Science Translational Medicine|October 5, 2012
Prevention of alveolar destruction and airspace enlargement in a mouse model of pulmonary lymphangioleiomyomatosis (LAM)Elena A Goncharova, Dmitry A Goncharov, Melane Fehrenbach, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 21, 2009
Targeted detoxification of selected reactive oxygen species in the vascular endotheliumVladimir V Shuvaev, Melpo Christofidou-Solomidou, Faiz Bhora, et al.
Journal of Critical Care|October 1, 2011
Lower serum endocan levels are associated with the development of acute lung injury after major traumaMark E Mikkelsen, Chirag V Shah, Arnaud Scherpereel, et al.
Breast Cancer Research and Treatment|March 16, 2012
Mesothelin, a novel immunotherapy target for triple negative breast cancerJulia Tchou, Liang-Chuan Wang, Ben Selven, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapyDaniel H Sterman, Adriana Recio, Anil Vachani, et al.
American Journal of Respiratory Cell and Molecular Biology|April 17, 2004
Role for platelet-endothelial cell adhesion molecule-1 in macrophage Fcgamma receptor functionSteven M Albelda, Kelvin C Lau, Paul Chien, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Gene expression profiling of malignant mesotheliomaSunil Singhal, Rainer Wiewrodt, Liliana D Malden, et al.
Biomaterials|October 24, 2007
Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapiesThomas D Dziubla, Vladimir V Shuvaev, Nan Kang Hong, et al.
Lung Cancer (Amsterdam, Netherlands)|November 5, 2019
Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracyJeffrey C Thompson, Wei-Ting Hwang, Christiana Davis, et al.
Pageof 20